Related Experiment Video

Updated: Jun 1, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Mutational analysis of VACM-1/cul5 exons in cancer cell lines

Steven P Lewis1, Angelica N Willis, Alyssa E Johnson

  • 1Department of Biology, Hope College, Holland, MI, USA.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|June 4, 2011
PubMed

Insights

VACM-1 (cul-5 gene product) exhibits antiproliferative effects, potentially regulated by post-translational modifications rather than mutations at key sites in breast cancer cells. Further research is needed to understand its role in cancer progression.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Genetics

Background:

  • VACM-1, a cul-5 gene product, functions in an E3 ligase complex and exhibits antiproliferative effects when overexpressed.
  • Post-translational modifications, like Nedd8 conjugation, influence VACM-1/cul-5 activity.
  • Decreased VACM-1 mRNA levels are observed in cancers, suggesting a role in cell proliferation, but genetic alterations remain unexamined.

Purpose of the Study:

  • To investigate potential mutations in the PKA-specific phosphorylation site or neddylation site of VACM-1/cul-5 in rapidly proliferating cancer cells.
  • To analyze genetic and epigenetic changes in the VACM-1/cul-5 gene sequence within various cancer cell lines.

Main Methods:

  • RT-PCR and PCR were employed to amplify and sequence mRNA and genomic DNA, respectively.
  • All 19 coding exons of the VACM-1/cul-5 gene were sequenced in T47D breast cancer, U138MG glioma, ACHN renal cancer, and OVCAR-3 ovarian cancer cells.

Main Results:

  • No mutations were found at the putative phosphorylation or neddylation sites of VACM-1/cul-5 in the analyzed cancer cell lines.
  • A single silent mutation was identified in the genomic DNA of U138MG, ACHN, and OVCAR-3 cells, but not in T47D cells.

Conclusions:

  • The antiproliferative activity of VACM-1/cul-5 in T47D breast cancer cells is likely regulated by post-translational modifications, not by mutations at the analyzed phosphorylation or neddylation sites.
  • The findings suggest that genetic alterations at these specific sites are not the primary drivers of VACM-1/cul-5 dysfunction in these cancer types.

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.